Project Grant HT94252410577
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$813K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $829,986.00 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to conduct research titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". This 3-year grant, effective September 30, 2023, aims to advance innovative biomedical research into melanoma prevention...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public...
The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
The Trustees of the University of Pennsylvania received a $296,595 Project Grant award from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2025. The grant supports the "Controlling the Burden of Metastatic Disease in Pancreatic Ductal Adenocarcinoma" project conducted in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...
The University of Pennsylvania has been awarded a $650,001.50 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports a clinical trial site application for the Kidney Cancer Research Consortium, with a performance period from September 15, 2024 to September 14, 2026. As a leading academic medical center, the University of Pennsylvania will leverage its extensive research capabilities and...
The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...